![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
34 min
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
BPDCN treatment and management: CD123-targeting agents, CNS involvement & approaching pediatric/AYA patients VJHemOnc Podcast
-
- Medicin
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive hematologic malignancy originating from plasmacytoid dendritic cells, characterized by skin lesions...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive hematologic malignancy originating from plasmacytoid dendritic cells, characterized by skin lesions...
34 min